IP Library Granted Patent US 7,582,053
Granted Patent B2
US 7,582,053 · App. 10/671,144 · Granted Sep 1, 2009

Control of urge incontinence

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,582,053
App. No.
10/671,144
Granted
Sep 1, 2009
Kind
B2
Abstract

A device ( 20 ) for treatment of a patient's urinary incontinence, including a sensor, ( 44 ), which generates a signal responsive to a physiological characteristic indicative of a likelihood of incontinence. A control unit ( 22 ) receives the signal from the sensor. At least one electrode ( 29 ) is preferably implanted in the patient. The electrode is coupled to cause contraction of a pelvic muscle of the patient responsive to application of electrical energy to the electrode. Responsive to the signal, the control unit applies an electrical waveform to the electrode, so as to inhibit the incontinence.

Claims (25)

1. A method comprising:

implanting at least one electrode in a patient in contact with a pelvic muscle of the patient;

implanting a stimulator device in the patient; and

driving the at least one electrode to apply a biphasic electrical waveform to the muscle using the stimulator device.

2. The method according to claim 1 , wherein implanting the at least one electrode comprises implanting the at least one electrode in the pelvic muscle.

3. The method according to claim 1 , further comprising contracting the pelvic muscle in response to driving the at least one electrode, wherein urine flow through a urethra of the patient is inhibited.

4. The method according to claim 3 , wherein driving the at least one electrode comprises configuring the waveform to treat urinary urge incontinence.

5. The method according to claim 3 , wherein driving the at least one electrode comprises configuring the waveform to treat stress incontinence.

6. A method comprising:

implanting at least one elongated electrode structure in contact with a pelvic muscle of the patient;

implanting a stimulator device in the patient;

driving the at least one electrode to apply an electrical waveform to the muscle using the stimulator device;

providing for the electrical waveform a plurality of pulses each having pulse width duration of 2 ms or less; and

contracting the pelvic muscle in response to driving the at least one electrode, wherein urine flow through the urethra of the patient is inhibited.

7. The method according to claim 6 , wherein implanting the at least one electrode comprises implanting the at least one electrode in the pelvic muscle.

8. The method according to claim 6 , wherein providing for the electrical waveform comprises setting the pulse width durations of the pulses within a range of 0.1 ms to 2 ms.

9. The method according to claim 6 , wherein the plurality of pulses each have a pulse width duration of less than 1 ms.

10. The method according to claim 6 , wherein driving the at least one electrode comprises configuring the waveform to treat urinary urge incontinence.

11. The method according to claim 6 , wherein driving the at least one electrode comprises configuring the waveform to treat stress incontinence.

12. The method according to claim 6 , wherein the pelvic muscle includes the levator ani muscle, and wherein implanting the at least one electrode comprises implanting the at least one electrode in the levator ani muscle.

13. The method according to claim 6 , wherein the pelvic muscle includes the urethral sphincter muscle, and wherein implanting the at least one electrode comprises implanting the at least one electrode in the urethral sphincter muscle.

14. The method according to claim 6 , further comprising terminating application of the waveform to the muscle after a predetermined period of time.

15. The method according to claim 14 , wherein the predetermined period of time is about 5 seconds.

16. The method according to claim 14 , wherein driving the at least one electrode comprises driving the at least one electrode to reapply the waveform after termination of the application of the waveform.

17. The method according to claim 6 , wherein driving the at least one electrode comprises providing for the waveform a biphasic electrical waveform.

Assignments (16)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0491 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2018
From: BIOCONTROL ,EDICAL (B.C.M.) LTD
To: MEDTRONIC, INC.
Reel/Frame 046574/0208 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0607. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 11, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037514/0402 →
CHANGE OF NAME Recorded Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0425 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0607 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
SECURITY AGREEMENT Recorded Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Apr 27, 2011
From: MEDTRONIC, INC.
To: BIO CONTROL MEDICAL (B.C.M.) LTD
Reel/Frame 026186/0580 →
SECURITY AGREEMENT Recorded May 20, 2010
From: BIO CONTROL MEDICAL (B.C.M.) LTD
To: MEDTRONIC, INC.
Reel/Frame 024411/0365 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2008
From: BIOCONTROL MEDICAL, LTD.
To: AMS RESEARCH CORPORATION
Reel/Frame 020375/0569 →